Blog Archives

Blog

New FDA Requirement to Support Labeling on DDIs in the Pediatric Population

The effects of drug-drug interactions (DDIs) could differ in the pediatric population compared to adults.…

Certara2022年12月21日

Blog

The Phoenix Workflow Shortcuts Every Pharmacokineticist Needs

Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform can revolutionize your pharmaceutical organization’s approach to PK/PD…

Certara2022年12月16日

Blog

Tips & Tricks for Data Management in Phoenix WinNonlin

Learn some tips & tricks for the Data Wizard, a data management tool in Phoenix,…

Certara2022年11月18日

Blog

Tips to Use Phoenix WinNonlin More Efficiently

Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform is the single, interoperable hub for sharing pre-clinical…

Certara2022年11月7日

Blog

乳児・新生児における PBPK モデリング＆シミュレーションの役割

Many factors make it challenging to obtain adequate pediatric samples for use in drug development…

Certara2022年11月4日

Blog

臨床試験を開始する前に製剤を選択すべき理由

創薬企業はしばしば、ヒトでの試験を急ぐあまり、創薬プロセスを駆け足で進めてしまうことがあります。Most are…

Certara2022年10月28日

Blog

PBPK Modeling & Simulation of Therapeutic Oligonucleotides from Bench to Bedside

Next generation therapeutics Oligonucleotide drugs are unique among therapeutic modalities in that they don’t engage…

Certara2022年10月14日

Blog

The Growing Value of Quantitative Systems Pharmacology (QSP)

Gain a foundational understanding of QSP in this 101-level article with examples of QSP applied…

Certara2022年10月7日

Blog

Choosing a Clinical Trial Transparency and Disclosure Vendor: Your Complete Checklist

Choosing the right technology and services vendor to support your organization’s transparency and disclosure (T&D)…

Certara2022年10月4日

Blog

5 Steps to Satisfy New EU-CTR Requirements for Plain Language Summaries of Clinical Study Results

For the first time, the European Medicines Agency (EMA) has passed new regulations to help…

Certara2022年9月27日

Powered by Translations.com GlobalLink Web Software

ブログ

New FDA Requirement to Support Labeling on DDIs in the Pediatric Population

The Phoenix Workflow Shortcuts Every Pharmacokineticist Needs

Tips & Tricks for Data Management in Phoenix WinNonlin

Tips to Use Phoenix WinNonlin More Efficiently

乳児・新生児における PBPK モデリング＆シミュレーションの役割

臨床試験を開始する前に製剤を選択すべき理由

PBPK Modeling & Simulation of Therapeutic Oligonucleotides from Bench to Bedside

The Growing Value of Quantitative Systems Pharmacology (QSP)

Choosing a Clinical Trial Transparency and Disclosure Vendor: Your Complete Checklist

5 Steps to Satisfy New EU-CTR Requirements for Plain Language Summaries of Clinical Study Results

メルマガ登録

クイックアクセス

ソリューション

お問合せ